Newsletter | February 23, 2021

02.23.21 -- Current Trends And Challenges In Clinical Trials

Decentralized Clinical Trials: Are They Here To Stay?

In 2020, the clinical trial industry adapted and responded in rapid fashion. Measures were taken to allow for continuity of studies, all while shortening timelines and ensuring safety and flexibility of care. This response by the industry was impressive and perhaps provides a glimpse into the future of clinical research. But what does the future look like?

The Impact Of COVID-19 On Research Sites: Planning For The Road Back To Full Trial Operations

COVID-19 has had a dramatic impact on U.S. clinical care, including how sites have worked to maintain research operations throughout the pandemic. The financial and logistical challenges faced by our site partners have been substantial. Here is a recap of the adaptations they’ve made to manage through the current environment.

Advancing Diversity In Clinical Trials: Building Awareness And Implementing Solutions To Enable Broad Participation In Research

The underrepresentation of certain populations in clinical research is a serious problem. However, sponsors and CROs are renewing their focus on diversity and are looking for new ways to create awareness and remove obstacles through patient-centered solutions.

Increasing Site And Patient Convenience For Oncology Clinical Trials

Once a patient is enrolled, there are many obstacles that can impact patient retention in a study. This article discusses some of the obstacles facing oncology research today and highlights innovation opportunities to transform the way sites, sponsors, and CROs interact.

Removing Clinical Trial Travel Logistics In The Height Of The COVID-19 Pandemic

With the current clinical trial logistical challenges there comes the need for ingenuity — partnering with a travel provider who can navigate these difficult and uncertain times to ensure sustainability for the trial.